IP Library Granted Patent US 8,454,527
Granted Patent B2
US 8,454,527 · App. 12/972,225 · Granted Jun 4, 2013

Minimally invasive determination of collateral ventilation in lungs

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,454,527
App. No.
12/972,225
Granted
Jun 4, 2013
Kind
B2
Abstract

Minimally invasive methods, systems and devices are provided for qualitatively and quantitatively assessing collateral ventilation in the lungs. In particular, collateral ventilation of a target compartment within a lung of a patient is assessed by advancement of a catheter through the tracheobronchial tree to a feeding bronchus of the target compartment. The feeding bronchus is occluded by the catheter and a variety of measurements are taken with the use of the catheter in a manner which is of low risk to the patient. Examples of such measurements include but are not limited to flow rate, volume and pressure. These measurements are used to determine the presence of collateral ventilation and to quantify such collateral ventilation.

Claims (31)

1. A method of evaluating a target lung compartment of a patient, the method comprising:

positioning an instrument within a lung passageway leading to the target lung compartment so that the target lung compartment is isolated;

injecting an inert gas into the isolated target lung compartment;

generating at least one measurement of pressure within the target lung segment;

generating at least one measurement of concentration of inert gas within the target lung segment; and

analyzing the at least one target lung compartment using a processor with the use of the at least one measurement of pressure and the at least one measurement of concentration of inert gas, wherein analyzing comprises determining a degree of hyperinflation or a state of compliance.

2. A method as in claim 1 , further comprising determining a treatment plan at least partially based on the determined degree of hyperinflation.

3. A method as in claim 1 , further comprising determining a treatment plan at least partially based on the determined state of compliance.

4. A method as in claim 1 , wherein generating the at least one measurement of pressure comprises generating a plurality of measurements of pressure over a predetermined time period.

5. A method as in claim 4 , wherein the predetermined time period comprises approximately one minute.

6. A method as in claim 1 , wherein generating the at least one measurement of concentration of inert gas comprises generating a plurality of measurements of concentration of inert gas over a predetermined time period.

7. A method as in claim 6 , wherein the predetermined time period comprises approximately one minute.

8. A method as in claim 1 , wherein the inert gas comprises helium.

9. A method of evaluating a target lung compartment of a patient, the method comprising:

positioning an instrument within a lung passageway leading to the target lung compartment so that the target lung compartment is isolated;

injecting an inert gas into the isolated target lung compartment;

generating at least one measurement of pressure within the target lung segment;

generating at least one measurement of concentration of inert gas within the target lung segment;

analyzing the at least one target lung compartment with the use of the at least one measurement of pressure and the at least one measurement of concentration of inert gas, wherein analyzing comprises determining a collateral resistance; and

determining a treatment plan based on the determined collateral resistance.

10. A system for evaluating a target lung compartment comprising:

an instrument positionable within a lung passageway leading to the target lung compartment so that the target lung compartment is isolated, wherein the instrument includes a mechanism for injecting an inert gas to the target lung segment;

at least one sensor which generates measurement data reflecting pressure within the target lung segment;

at least one sensor which generates measurement data reflecting concentration of an inert gas within the target lung segment; and

a processor which performs computations with the use of the measurement data reflecting pressure and the measurement data reflecting concentration of inert gas, wherein the computations include calculating a degree of hyperinflation or state of compliance of the target lung compartment.

11. A system as in claim 10 , wherein the computations include calculating collateral resistance of the target lung compartment.

12. A system as in claim 10 , wherein the measurement data reflecting pressure comprises generating a plurality of measurements of pressure over a predetermined time period.

13. A system as in claim 12 , wherein the predetermined time period comprises approximately one minute.

14. A system as in claim 10 , wherein the measurement data reflecting concentration of inert gas comprises generating a plurality of measurements of concentration of inert gas over a predetermined time period.

15. A system as in claim 14 , wherein the predetermined time period comprises approximately one minute.

16. A system as in claim 10 , wherein the inert gas comprises helium.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Mar 4, 2026
From: CANADIAN IMPERIAL BANK OF COMMERCE
To: PULMONX CORPORATION
Reel/Frame 075028/0274 →
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2020
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: PULMONX CORPORATION
Reel/Frame 053952/0044 →
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2020
From: BOSTON SCIENTIFIC CORPORATION
To: PULMONX CORPORATION
Reel/Frame 053953/0548 →
SECURITY INTEREST Recorded Mar 2, 2020
From: PULMONX CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 052916/0213 →
MERGER Recorded Apr 23, 2019
From: PULMONX
To: PULMONX CORPORATION
Reel/Frame 048964/0563 →
SECURITY INTEREST Recorded Jul 26, 2017
From: PULMONX CORPORATION
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 043349/0725 →
SECURITY INTEREST Recorded May 15, 2017
From: PULMONX CORPORATION
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 042466/0349 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 27, 2015
From: ALJURI, NIKOLAI; WONDKA, ANTHONY; SURJAN, GEORGE; DAVIS, KIRK; SOLTESZ, PETER; PERKINS, RODNEY C.
To: PULMONX
Reel/Frame 035719/0981 →